These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 33999741)

  • 21. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
    Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
    JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status.
    Pro G; Tompkins DA; Azari S; Zaller N
    Drug Alcohol Depend; 2021 Nov; 228():109092. PubMed ID: 34571287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.
    Askari MS; Martins SS; Mauro PM
    J Subst Abuse Treat; 2020 Jul; 114():108028. PubMed ID: 32527510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inpatient opioid use after vaginal delivery.
    Badreldin N; Grobman WA; Yee LM
    Am J Obstet Gynecol; 2018 Dec; 219(6):608.e1-608.e7. PubMed ID: 30171846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.
    Abraham AJ; Yarbrough CR; Harris SJ; Adams GB; Andrews CM
    Psychiatr Serv; 2021 Feb; 72(2):148-155. PubMed ID: 33267651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder.
    Mojtabai R; Mauro C; Wall MM; Barry CL; Olfson M
    Psychiatr Serv; 2019 Jul; 70(7):617-620. PubMed ID: 31035894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey.
    Bandara S; Maniates H; Hulsey E; Smith JS; DiDomenico E; Stuart EA; Saloner B; Krawczyk N
    BMC Health Serv Res; 2022 Mar; 22(1):418. PubMed ID: 35354460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Hospitalized Adults with Opioid Use Disorder in the United States: Nationwide Inpatient Sample.
    Alemu BT; Olayinka O; Martin BC
    Pain Physician; 2021 Aug; 24(5):327-334. PubMed ID: 34323434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of legal mandates on substance use disorder treatment completion among older adults.
    Pickard JG; Sacco P; van den Berk-Clark C; Cabrera-Nguyen EP
    Aging Ment Health; 2020 Mar; 24(3):497-503. PubMed ID: 30588828
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.
    Stahler GJ; Mennis J
    Drug Alcohol Depend; 2020 Jul; 212():108067. PubMed ID: 32445926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "
    Checkley L; Steiger S; Knight KR
    Subst Abus; 2022; 43(1):767-773. PubMed ID: 35112998
    [No Abstract]   [Full Text] [Related]  

  • 34. Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders.
    Winetsky D; Weinrieb RM; Perrone J
    J Hosp Med; 2018 Jan; 13(1):62-64. PubMed ID: 29073311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating Buprenorphine Into an Opioid Treatment Program: Tailoring Care for Patients With Opioid Use Disorders.
    Polydorou S; Ross S; Coleman P; Duncan L; Roxas N; Thomas A; Mendoza S; Hansen H
    Psychiatr Serv; 2017 Mar; 68(3):295-298. PubMed ID: 27745534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Medicaid Expansion and Rates of Opioid-Related Hospital Use.
    Wen H; Soni A; Hollingsworth A; Freedman S; Benitez J; Simon K; Saloner B
    JAMA Intern Med; 2020 May; 180(5):753-759. PubMed ID: 32202609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol education provided to opioid treatment program patients: results of a nationwide survey.
    Strauss SM; Harris G; Katigbak C; Rindskopf DM; Singh S; Greenblum I; Brown LS; Kipnis S; Kritz SA; Parrino MW
    J Drug Educ; 2010; 40(4):379-93. PubMed ID: 21381464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit.
    Xie L; Joshi AV; Schaaf D; Mardekian J; Harnett J; Shah ND; Baser O
    Pain Pract; 2014 Jun; 14(5):446-56. PubMed ID: 23809064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient Characteristics Affect Discharge Status for Opioid-related Infective Endocarditis.
    Schuller KA; Franz B; Cronin CE
    Med Care; 2020 Jan; 58(1):13-17. PubMed ID: 31651741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington.
    Amiri S; Lutz R; Socías ME; McDonell MG; Roll JM; Amram O
    J Subst Abuse Treat; 2018 Oct; 93():26-30. PubMed ID: 30126538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.